Alling et al., 1971 - Google Patents
Lipid alterations in apparently normal white matter in multiple sclerosisAlling et al., 1971
- Document ID
- 8505063551029884836
- Author
- Alling C
- Svennerholm L
- et al.
- Publication year
- Publication venue
- Brain research
External Links
Snippet
Apparently normal white matter from 6 subjects who had multiple sclerosis (MS) for 5–41 years was compared with roughly age-matched normal material. Determinations were made of the concentrations and fatty acid patterns of all major lipid classes except gangliosides …
- 150000002632 lipids 0 title abstract description 46
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P-C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alling et al. | Lipid alterations in apparently normal white matter in multiple sclerosis | |
Scott et al. | Lipid composition and metabolism in testicular and ejaculated ram spermatozoa | |
Greiner et al. | Phospholipids in meibomian gland secretion | |
Rosenberg et al. | Changes in sphingosine and fatty acid components of the gangliosides in developing rat and human brain | |
Gjone et al. | Familial Plasma Cholesterol Ester Deficiency a study of the erythrocytes | |
Davison et al. | Analysis of lipids from fresh and preserved adult human brains | |
Hildebrand et al. | Neutral glycolipids in leukemic and nonleukemic leukocytes | |
Crowley et al. | Human fetal erythrocyte and plasma lipids | |
US5856196A (en) | Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor | |
Veerkamp et al. | Comparative studies on the phosphatides of normal rat liver and primary hepatoma | |
Gillett et al. | Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseases | |
Cherayil | Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis | |
Woelk et al. | Lipid and fatty acid composition of myelin purified from normal and MS brains | |
Kahma et al. | Low and moderate concentrations of lysobisphosphatidic acid in brain and liver of patients affected by some storage diseases | |
Leaver et al. | Distribution of arachidonic acid and other fatty acids in the lipids of guinea-pig uterus and plasma in relation to uterine prostaglandin synthesis | |
Svennerholm et al. | Lipid and fatty acid composition of human cerebral myelin during development | |
Brown et al. | Methods of evaluating fetal lung maturity | |
Menkes et al. | Maternal phenylketonuria: The composition of cerebral lipids in an affected offspring | |
Howard et al. | Lipid changes in the plasma lipoproteins of baboons given an atherogenic diet: Part 3. A comparison between lipid changes in the plasma of the baboon and chimpanzee given atherogenic diets and those in human plasma lipoproteins of type ii hype rlipoproteinaemia | |
Privett et al. | Quantitative analysis of lipid classes | |
Witer et al. | Lipid Investigation of Central and Peripheral Nervous System in Connatal Pelizaeus‐Merzbacher's Disease | |
Tjiong et al. | Lysosomal bis (monoacylglycero) phosphate of rat liver, its induction by chloroquine and its structure | |
Bruce | Skeletal muscle lipids. II. Changes in phospholipid composition in man from fetal to middle age | |
Berry et al. | Dietary fat, plasma lipoproteins, and immune function in middle‐aged American men | |
Angervall et al. | The lipid composition of hibernoma as compared with that of lipoma and of mouse brown fat |